4 symposiums on Oncology, General Biologics, Immunology and Cardiology at 6th annual BioPharma Asia Convention 2013. Research on Oncology, Cardiology, Immunology and General Biologics continues to be one of the key areas amongst leading scientists and academia in Asia. The 6th BioPharma Asia Convention 2013 is pleased to announce that National Cancer Centre, National University Heart Centre Singapore, National University of Singapore- Department of Microbiology and Nanyang Technological University of Singapore – School of Chemical and Biomedical Engineering, will be the hosts for these key areas of research.
Topics that would be covered at these symposiums include:
- Transcontinental networks, biobanks and translational research at the National University Heart Centre, Singapore
- Dealing with cancer and obesity
- Novel disease markers for cancer detection
- Targeting proteome homeostasis, a new approach to antimycobacterial drug discovery
- Design strategies for peptide and proteins as druggable biologics
List of pharmas and academia who will be also presenting at our onfloor seminars include:
- Baxter Bioscience
- Bristol Myers Squib
- Johnson & Johnson
For more detailed information about the event, please visit: www.terrapinn.com/biopharma
BioPharma Asia Convention is the largest biopharmaceutical event in Asia where 4000+ global and Asian biotech and pharmaceutical stakeholders come together to discuss issues, strategies, innovations and partnerships across the industry. Over 4 days with 7 different conferences tracks on partnering, stem cells, drug discovery, biologic manufacturing, sustainable manufacturing, clinical trials and supply chain, industry leaders and key decision makers from across the globe come together in Singapore for discussions and networking opportunities to determine the trends and strategies for the year ahead.
Name: Jolene Lee
Position: Marketing Manager, Terrapinn, Singapore
Contact number: +65 6322 2318